Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    September 2025
  1. POLKAMPALLY S, Halagur AS, Green A, Wei E, et al
    Incidence of Pediatric Graves' Disease in the United States: An Epidemiological Analysis of 2007-2022 Outpatient Insurance Claims.
    Thyroid. 2025 Sep 22. doi: 10.1177/10507256251382559.
    PubMed     Abstract available


    August 2025
  2. CHOU YT, Lai CC, Li CY, Shen WC, et al
    Early Statin Use Following Diagnosis of Graves' Disease Is Associated with a Reduced Risk of Moderate-to-Severe Graves' Orbitopathy in Middle-Aged Adults: Evidence from a Nationwide Taiwanese Cohort.
    Thyroid. 2025 Aug 13. doi: 10.1177/10507256251364782.
    PubMed     Abstract available


    July 2025
  3. CIAMPA DA, Comi S, Cosentino G, Menconi F, et al
    Letter: Prolonged Treatment with Sirolimus (Rapamycin) for Graves' Orbitopathy.
    Thyroid. 2025 Jul 29. doi: 10.1177/10507256251363145.
    PubMed    


  4. XIANG P, Latif R, Davies TF
    The Thyrotropin Receptor Antibody Reactome Determines Thyroid and Retro-orbital Responsiveness.
    Thyroid. 2025 Jul 14. doi: 10.1177/10507256251359557.
    PubMed     Abstract available


    June 2025
  5. LIU J, Zhu T, Yang L, Qian W, et al
    Cigarette Smoking Drives Thyroid Eye Disease Progression via RAGE Signaling Activation.
    Thyroid. 2025 Jun 12. doi: 10.1089/thy.2025.0062.
    PubMed     Abstract available


    May 2025
  6. VILLAGELIN D, Cooper DS, Burch HB
    Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists.
    Thyroid. 2025 May 28. doi: 10.1089/thy.2024.0759.
    PubMed     Abstract available


    April 2025
  7. ROZTOCIL E, Husain F, Patrick CC, Feldon SE, et al
    Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0529.
    PubMed     Abstract available


    March 2025
  8. BACZEWSKA N, Alexopoulou O, Constantinescu SM, Daumerie C, et al
    Factors Associated with Response to Intravenous Glucocorticoids in Active Moderate-to-Severe Thyroid Eye Disease.
    Thyroid. 2025 Mar 7. doi: 10.1089/thy.2024.0629.
    PubMed     Abstract available


    February 2025
  9. BARTALENA L, Tanda ML
    Is Radioactive Iodine Contraindicated in Patients with Moderate-to-Severe and Active Graves' Orbitopathy?
    Thyroid. 2025 Feb 12. doi: 10.1089/thy.2025.0059.
    PubMed    


  10. COSENTINO G, Lanzolla G, Comi S, Maglionico MN, et al
    Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.
    Thyroid. 2025 Feb 5. doi: 10.1089/thy.2024.0633.
    PubMed     Abstract available


  11. SMITH TJ
    Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy.
    Thyroid. 2025 Feb 5. doi: 10.1089/thy.2024.0606.
    PubMed     Abstract available


    January 2025
  12. CHOU YT, Lai CC, Li CY, Shen WC, et al
    Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study.
    Thyroid. 2025 Jan 13. doi: 10.1089/thy.2024.0536.
    PubMed     Abstract available


    December 2024
  13. ZAJNER C, Patil N, McInnis R, Van Uum S, et al
    Patterns of Extraocular Muscle Enlargement in Graves' Orbitopathy and Acromegaly.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0438.
    PubMed     Abstract available


  14. CHO YY, Kim B, Jin SM, Jung CH, et al
    Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0270.
    PubMed     Abstract available


    October 2024
  15. XIANG P, Latif R, Morshed S, Davies TF, et al
    Hypothyroidism Induced by a TSH Receptor Peptide-Implications for Thyroid Autoimmunity.
    Thyroid. 2024 Oct 22. doi: 10.1089/thy.2024.0089.
    PubMed     Abstract available


  16. LEE HS, Lee J, An HJ, Sung MJ, et al
    Mitophagy Defects Exacerbate Inflammation and Aberrant Proliferation in Lymphocytic Thyroiditis.
    Thyroid. 2024 Oct 14. doi: 10.1089/thy.2024.0125.
    PubMed     Abstract available


    September 2024
  17. ELLERVIK C, Boulakh L, Teumer A, Marouli E, et al
    Thyroid function, diabetes, and common age-related eye diseases - a Mendelian randomization study.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0257.
    PubMed     Abstract available


  18. RACHMASARI KN, Hamadi D, Thapa P, Bradley E, et al
    The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota 2005-2020.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0304.
    PubMed     Abstract available


  19. LEE JY, Lee MK, Lee JH, Kim K, et al
    Cancer risks of patients with Graves' disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis.
    Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
    PubMed     Abstract available


    August 2024
  20. HANDLER S, Lee SY
    Risk of Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism after Pregnancy is Associated with Underlying Thyroid Autoimmunity.
    Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0435.
    PubMed     Abstract available


    June 2024
  21. PERAMPALAM S, Wu K, Gild ML, Tacon L, et al
    Association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic review and meta-analysis.
    Thyroid. 2024 Jun 28. doi: 10.1089/thy.2024.0142.
    PubMed     Abstract available


  22. FUNG MHM, Luk Y, Yuen KK, Lang BHH, et al
    The two-year results of using radiofrequency ablation as a novel treatment for persistent or relapsed Graves' disease, a prospective study.
    Thyroid. 2024 Jun 5. doi: 10.1089/thy.2024.0177.
    PubMed     Abstract available


  23. KAHALY GJ, Subramanian PS, Conrad E, Holt RJ, et al
    Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials.
    Thyroid. 2024 Jun 2. doi: 10.1089/thy.2023.0656.
    PubMed     Abstract available


    April 2024
  24. HUANG N, Chen L, Yan Z, Zeng L, et al
    Intracytoplasmic sperm injection versus in vitro fertilization in infertile women with thyroid autoimmunity.
    Thyroid. 2024 Apr 16. doi: 10.1089/thy.2023.0676.
    PubMed     Abstract available


  25. SHIN K, Choung H, Lee MJ, Kim J, et al
    A preliminary evaluation of the diagnostic performance of a smartphone-based machine learning-assisted system for evaluation of clinical activity score in digital images of thyroid-associated orbitopathy.
    Thyroid. 2024 Apr 16. doi: 10.1089/thy.2023.0621.
    PubMed     Abstract available


  26. SCHEMPP V, Cebeci AN, Reinauer C, Woelfle J, et al
    Neutropenia occurs more often under carbimazole (CBZ) than under methimazole (MMI) treatment in pediatric Graves' disease patients.
    Thyroid. 2024 Apr 13. doi: 10.1089/thy.2023.0673.
    PubMed     Abstract available


    March 2024
  27. LIU S, Lu C, He L, Shan Z, et al
    Vitamin E intake and prevalence rates of thyroid dysfunction and autoimmune thyroiditis: A cross-sectional analysis of NHANES data.
    Thyroid. 2024 Mar 27. doi: 10.1089/thy.2023.0561.
    PubMed     Abstract available


    February 2024
  28. DUNTAS LH
    Reassessing Selenium for the Management of Hashimoto's Thyroiditis: the Selini* shines bright for AIT patients.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2024.0078.
    PubMed     Abstract available


    January 2024
  29. HUWILER VV, Maissen-Abgottspon S, Stanga Z, Muehlebach S, et al
    Selenium Supplementation in Patients with Hashimoto Thyroiditis - A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0556.
    PubMed     Abstract available


    December 2023
  30. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    PubMed     Abstract available


  31. SAWIN CT, Cooper DS
    The Origin of Antithyroid Drugs.
    Thyroid. 2023;33:1395-1401.
    PubMed     Abstract available


    November 2023
  32. COHEN-SELA E, Brener A, Raviv O, Yackobovitch-Gavan M, et al
    Outcomes in Maternal Graves' Disease: A Population-Based Mother-Infant Dyad Cohort Study.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0291.
    PubMed     Abstract available


  33. FENNEMAN AC, Boulund U, Collard D, Galenkamp H, et al
    Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid Participants.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0346.
    PubMed     Abstract available


  34. DOUGLAS RD, Parunakian E, Tolentino J, Malkhasyan E, et al
    A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0466.
    PubMed     Abstract available


    October 2023
  35. UYSAL M, Akgun E, Sarioglu AG, Berber E, et al
    Comparison of Perioperative Outcomes in Patients with Graves' Disease Undergoing Total Thyroidectomy with or without Near Infrared Auto-Fluorescence Imaging.
    Thyroid. 2023 Oct 28. doi: 10.1089/thy.2023.0360.
    PubMed     Abstract available


  36. KO J, Kim YJ, Choi SH, Lee CS, et al
    Yes-associated protein (YAP) mediates the transition from inflammation to fibrosis in Graves' orbitopathy.
    Thyroid. 2023 Oct 6. doi: 10.1089/thy.2023.0309.
    PubMed     Abstract available



  37. Correction to: Response to Mooij and van Trotsenburg re: ''Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity'' by Medici and Soheili-Nezhad. Thyroid 2023;33
    Thyroid. 2023 Oct 5. doi: 10.1089/thy.2023.0315.
    PubMed    


    September 2023
  38. PAPADOPOULOU A, Asvold BO, Burgess S, Kus A, et al
    Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study.
    Thyroid. 2023 Sep 29. doi: 10.1089/thy.2023.0272.
    PubMed     Abstract available


  39. KHAMISI S, Udumyan R, Sjolin G, Calissendorff J, et al
    Fracture incidence in Graves' disease: A population-based study.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0162.
    PubMed     Abstract available


  40. DE LEO S, D'Elia S, Grani G, Dondi F, et al
    A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.